A novel sialic acid-specific lectin has been isolated from Helicobacter pylori lysate using fetuin-agarose affinity chromatography followed by cleavage of the a(2,3) and a(2,6) linkages of sialic acids using neuraminidase. The protein had a molecular weight of 17.5 kDa on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and was identified by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry to be protein of unknown function with gene number HP0721. Recombinant HP0721 was shown to bind to fetuin-agarose and sialic acid-containing glycosphingolipids on thin-layer plates suggesting this protein may represent another sialic acid-specific adhesin of H. pylori. A H. pylori mutant defective for HP0721 was generated and its ability to bind to human AGS cells assayed.
Introduction
Helicobacter pylori is a microaerophilic, Gram-negative bacterium, the causative agent in active chronic gastritis [1, 2] . Persistent H. pylori infection is associated with the development of gastric and duodenal ulcer disease [3] [4] [5] and gastric carcinoma [6] . A prerequisite for H. pylori infection is an ability to adhere to host gastric epithelium. A number of putative adhesins have been identified in H. pylori and it appears that adhesion may well be a multi-factorial process. One receptor that has been identified as a critical adherence ligand for H. pylori are sialylated glycoconjugates or more specifically, a(2,3)-sialyllactose [7] [8] [9] [10] .
In the case of H. pylori strain J99, a sialic acid-binding adhesin, SabA has already been identified [11] . In addition, a sialyllactose-binding haemaglutininprecursor (HpaA) was identified as an immuno-reactive antigen using antisera from infected patients [12] . Whilst sialic acid is not ubiquitous in healthy stomach tissue, it is detectable in inflamed sites, indicating that interaction with sialic acids in the host may be important in the longer term pathology of H. pylori infections [11] . The aims of this study were to identify the candidate sialic acid-binding proteins of H. pylori strain 26695. In this study, we describe using fetuin-agarose affinity chromatography followed by neuraminidase treatment to identify a new sialic acid-binding adhesin of H. pylori. The protein, HP0721, has previously been shown to be cell surfaced localised using selective biotinylation [13] and to be present in the supernatant fraction [14] both of which are in keeping for a role for HP0721 in mediating bacterial/host interactions. 
Materials and methods

Bacterial strains and growth conditions
Helicobacter strain 26695 was cultured at 37°C in a micro-aerobic atmosphere (5% O 2 , 10% CO 2 and 85% N 2 ) on 5% horse blood-columbia agar plates for three days, and grown for one additional day on fresh plates.
Fetuin-agarose affinity chromatography
H. pylori were harvested by centrifugation at 4000g then lysed using 1 ml BugBuster Protein Extraction Reagent (Merck Biosciences, Nottingham, UK) plus 200 lg ml À1 lysozyme at room temperature for 2 h. Nucleic acids were degraded using 1 lg ml À1 DNase and 1 lg ml À1 RNase with incubation for 15 min at room temperature. After removal of intact bacteria by two centrifugations at 6000g for 10 min, the lysate was incubated with 100 ll fetuin-agarose beads (Sigma-Aldrich, Poole, Dorset, UK) overnight at 4°C. The beads were washed five times with 1 ml DulbeccoÕs phosphate-buffered saline (Sigma-Aldrich, Poole, Dorset, UK). To identify the total proteins binding to fetuin, sodium dodecyl sulfate (SDS)-loading buffer (4% SDS, 0.1 M Tris, pH 8.8, 2 mM EDTA, 0.1% bromophenol blue, 20% glycerol and 2% b-mercaptoethanol) was added, and the samples were boiled to release any proteins bound to the fetuin and analysed on SDS-polyacrylamide gel electrophoresis (SDS-PAGE). To identify sialic acid-specific binding proteins, the washed beads were incubated with 1 U neuraminidase type III from Vibrio cholerae (Sigma-Aldrich, Poole, Dorset, UK) in 0.1 M NaOAc, pH 5.5 and 4 mM CaCl 2 overnight at 37°C. This cleaves a(2,3) and a(2,6) linkages of sialic acids to remove the sialyllactose from fetuin and thus eluting any proteins bound to sialyllactose. The elution fraction was analysed on SDS-PAGE. Protein identification by MALDI-TOF was performed.
SDS-polyacrylamide gel electrophoresis and identification of proteins by mass spectrometry
Denaturing SDS-PAGE was carried out by the method of Laemmli [15] in 10% or 15% gels plus 5% stacking gel with the Bio-Rad Mini Protean II system (Bio-Rad, Hemel Hempstead, Hertfordshire, UK). Protein samples were denatured before electrophoresis for 5 min at 100°C in SDS-loading buffer (2% SDS, 0.05 M Tris, pH 8.9, 1 mM EDTA, 0.05% bromophenol blue, 10% glycerol and 0.125 M dithiothreitol (DTT)). Gels were electrophoresed at 100 V for 2 h and gels were stained with Coomassie Blue R-250. The molecular mass markers used were pre-stained SDS-PAGE molecular weight standard markers (Bio-Rad, Hemel Hempstead, Hertfordshire, UK).
For mass spectrometry, neuraminidase eluted proteins underwent polyacrylamide gel electrophoresis followed by Coomassie blue staining. The proteins were excised from the gel and digested with trypsin before analysis by MALDI-TOF (performed at the Mass Spectrometry Core Facility, University of Manchester, UK). The molecular weights of the peptide fragments were used for a homology search against the H. pylori (26695) database to identify the proteins.
2.4. Preparation of DNA, cloning, expression and HP0721 N-terminal sequencing H. pylori chromosomal DNA was prepared using the cetyltrimethylammonium bromide (CTAB) method [16] . Briefly, bacteria from plates were suspended in 10 mM Tris, pH 8, 1 mM EDTA, 0.5% SDS and 1.25 mg ml
À1
proteinase K for 1 h at 37°C. NaCl was added to a final concentration of 700 mM and 1% CTAB with incubation at 65°C for 10 min. The DNA was extracted twice using phenol:chloroform:isoamyl alcohol (IAA) (25:24:1), once with chloroform:IAA (24:1). The DNA was precipitated with 0.7 volumes of isopropanol-acetate and resuspended in water.
The HP0721 gene was PCR amplified using primers HP0721F 5 0 AGAATTCCATATGAAAAAAGCGTTG AAAATAC containing a NdeI site and HP0721R 5 0 GGACTCGAGTTAGTGCTTATCGCTGTG containing a XhoI site or HP0721HISR 5 0 GTACTC GAGGTGCTTATCGCTGTGATC with the native stop codon removed and XhoI site. Amplification was performed in a volume of 50 ll containing 1· Taq DNA polymerase buffer, 125 lM each dNTPs, 20 pmol each primer, 2 U Taq DNA polymerase (Roche Molecular Biochemicals, Lewes, East Sussex, UK) and 0.1 lg of chromosomal DNA. The amplification conditions were as follows; initial denaturation of DNA at 95°C for 2 min, followed by 30 cycles of 95°C for 1 min, 55°C for 1 min, 72°C for 1 min, with a final extension at 72°C for 10 min. The generated PCR fragments (460 bp) were digested with NdeI/XhoI and ligated into pET24b/ NdeI/XhoI (Merck Biosciences, Nottingham, UK). The resulting plasmids were designated pET0721 and pET0721His, the inserts were confirmed by sequencing.
Escherischia coli BL21 (DE3) cells were transformed with the recombinant plasmids. The cells were grown at 37°C in LB medium containing 50 lg ml À1 kanamycin to an OD 600 of 0.6 and HP0721 expression was induced with 0.1 mM isopropyl-b-D D-thiogalacto pyranoside for 2 h. The cells were harvested by centrifugation at 4000g and then lysed using 5 ml BugBuster Protein Extraction Reagent (Merck Biosciences, Nottingham, UK) per gram of pellet plus 200 lg ml À1 lysozyme at room temperature for 15 min. Nucleic acids were degraded using 1 lg ml À1 DNase and 1 lg ml À1 RNase and incubating for 15 min at room temperature. After removal of intact bacteria by two centrifugations at 6000g for 10 min, the lysate was incubated with 100 ll fetuin-agarose beads (Sigma-Aldrich, Poole, Dorset, UK) overnight at 4°C. The beads were washed five times with 1 ml DulbeccoÕs phosphate-buffered saline. SDS-loading buffer is added and the beads boiled to release any bound proteins and analysed on 15% SDS-PAGE.
Following gel electrophoresis, the proteins were transferred to PVDF membrane and stained with Coomassie blue. The HP0721 bands were excised from the gel and N-terminal sequencing analysis was performed at the University of Cambridge (UK) under the supervision of Dr. Weldon.
Site-directed mutagenesis
The oligonucleotides used for site-directed mutagenesis of Leu 18 of HP0721 into Ala are L18AF 5 0 GCTATTTGTGGCTGCGAACGCCAAAGATTTC and L18AR 5 0 GAATCTTTGGCGTTCGCACCAC AAATAGC. Mutagenesis was performed using the Quick-Changeä site-directed mutagenesis kit from Stratagene (La Jolla, CA), according to the manufacturerÕs instructions. The presence of the correct mutation was verified by DNA sequencing.
Thin-layer chromatography overlay assay
TLC was performed essentially as described earlier [17] with a solvent system involving chloroform-methanol-water (60:35:8). Briefly, 2.5 lg pure glycolipids (Merck Biosciences, Nottingham, UK) were separated on high-performance TLC (HPTLC) aluminium-backed silica gel 60 plates (Merck Biosciences, Nottingham, UK). Glycolipids were stained with orcinol spray (Sigma-Aldrich, Poole, Dorset, UK). For the overlay assay, the plates were treated for 90 s with 0.1% Degalan P28 (Rohm GmbH & Co, Darmstadt, Germany) in diethylether-n-hexane and were air-dried. The plates were blocked with 2% bovine serum albumin (BSA) in Trisbuffered saline (TBS, 10 mM Tris, pH 7.4, 154 mM NaCl) for 90 min at room temperature and were washed once with TBS. Lysates of E. coli expressing His-tagged HP0721 containing 1% BSA were overlayed on the TLC plate for 2 h. The plates were washed three times with TBS-0.05% Tween-20 and once with TBS. HP0721 His-tagged protein was detected with the polyhistidine monoclonal antibody (Roche Molecular Biochemicals, Lewes, East Sussex, UK) directed against the hexa-His tag present at the C-terminal domain of HP0721 His-fusion protein. TLC overlay plates are probed with the polyhistidine monoclonal antibody (1:3000, Sigma-Aldrich, Poole, Dorset, UK). Immunoreactive proteins were detected by incubation with horseradish peroxidase-conjugated sheep anti-mouse antibody (1:2000, Amersham Pharmacia) and visualised using the 3,3-diamino benzidine (DAB)-peroxidase substrate tablet set (Sigma-Aldrich, Poole, Dorset, UK).
Construction of a mutant strain of H. pylori
For construction of a mutant strain, the HP0721 gene was amplified by PCR from a chromosomal DNA preparation of H. pylori strain 26695 and the amplified fragment was inserted into pGEM Ò -T Easy Vector (Promega, Southampton, UK). A kanamycin-resistance gene cassette with transcription termination signal (kan) was inserted into a genetically engineered BamHI site in the centre of the HP0721 gene. The plasmid was used for inactivation of chromosomal genes by natural transformation as previously described [18] . Inactivation of the gene was confirmed by PCR amplification and a protein lysate preparation of the mutant was prepared and analysed on SDS-PAGE to confirm loss of protein.
Epithelial cells
AGS cell line was derived from a human gastric adenocarcinoma and was obtained from the American Type Culture Collection (ATCC). The cells were maintained in RPMI 1640 medium supplemented with 10% FBS. For splitting, monolayers were detached by the use of 0.05% trypsin and 0.53 mM EDTA (Gibco-Invitrogen, Paisley, UK). After 5 min at 37°C, the trypsin was neutralised by washing in medium. For binding studies, cells were plated in flat-bottom 96-well microtitre plates in 200 ll of culture medium at 5 · 10 4 cells ml À1 . They reached confluence in 2 days. The cells were fixed in phosphate-buffered paraformaldehyde (3.5%) at room temperature for 20 min, followed by incubation with 100 mM glycine in PBS for 10 min and finally washing twice in PBS.
Bacterial binding experiments
H. pylori from a one-day-old plate was resuspended in PBS, 1 mM MgCl 2 and 1 mM CaCl 2 . The bacteria were adjusted to an OD 600 of 2.0 and labelled with fluorescein isothiocyanate (FITC) (Sigma-Aldrich, Poole, Dorset, UK) according to the previously published protocol [19] . 1 · 10 7 bacteria ml À1 were added to fixed confluent monolayers of AGS cells in microtitre wells in 50 ll. The bacteria were incubated with the cell monolayer overnight at 4°C. Microtitre wells were washed three times with 100 ll PBS, 1 mM MgCl 2 and 1 mM CaCl 2 to remove unbound bacteria. The number of bacteria was quantified using a BIO-TEK Synergy HT plate reader and excitation of the FITC at 485 nm and detection of the FITC fluorescent emission at 525. Inhibition of bacterial binding was measured by pre-incubating the bacteria with 1 mg ml À1 fetuin, 1 mg ml À1 asialofetuin or 2 mg ml À1 a(2,3)-sialyllactose for 30 min at room temperature with gentle rotation, before addition of the mixture to the fixed epithelial cell monolayers. All experiments were performed in triplicate.
Results
Isolation of a novel sialic acid-binding protein
Sialylated glycolipids have been shown to mediate important pathogen-host interactions in H. pylori colonisation [7] [8] [9] [10] [11] [12] . To identify sialic acid-specific proteins, we have used fetuin-agarose affinity chromatography followed by the cleavage of a(2,3) and a(2,6) sialic acid linkages by neuraminidase to elute any proteins bound to the terminal sialic acid residues of fetuin. Using this method, a protein with molecular weight of 17.5 kDa was eluted (Fig. 1) . This protein was also evident in total proteins that bind to fetuin-agarose (Fig. 2) . The protein was identified by MALDI-TOF to be HP0721, a protein of unknown function.
Production of recombinant HP0721
The next stage was to establish that the HP0721 gene was expressed in E. coli and that the HP0721 protein made showed biological properties similar to those of native HP0721 isolated from H. pylori. The HP0721 gene was successfully cloned into pET24b vector, to allow the expression of an untagged and C-terminal Histagged HP0721 in E. coli BL21 (DE3). Lysates were made from E. coli expressing recombinant untagged and his-tagged HP0721. The recombinant proteins both bound to fetuin-agarose beads but appear to have an increased aberrant molecule weight when analysed by SDS-PAGE as compared to native HP0721 purified from H. pylori (Fig. 3) . HP0721 protein has a classic signal sequence, which will direct the protein to the outer membrane in H. pylori. N-terminal sequencing revealed that the recombinant proteins were not being processed by signal peptidase I in E. coli. The sequence MKKALKI was obtained. This may be due to a subtle difference in the amino acid requirement for cleavage between H. pylori and E. coli. Both pathways require a short, positively charged amino-terminal region (nregion); a central hydrophobic region (h-region); and a more polar carboxy-terminal region (c-region) containing the site that is cleaved by the signal peptidase [20] . In H. pylori around 60% of outer-membrane proteins have a leucine residue at position À3 relative to cleavage (including HP0721); this is in contrast to most other Gram-negative bacterial signal sequences, where alanine is found 10 times more often than leucine [21] . With this information, a HP0721 construct was prepared that has the leucine in position À3 mutated to alanine. The L18A Fig. 1 . 12% SDS-PAGE of the neuraminidase-cleavage elution fraction following fetuin-agarose affinity chromatography of H. pylori lysate. Lane 1: H. pylori lysates were incubated with fetuin-agarose, washed three times and specific proteins bound to sialic acid residues on the fetuin were eluted by treatment with neuraminidase. The elution fraction is added to SDS-loading buffer and analysed. Lane 2: Fetuinagarose beads treated with neuraminidase. Fig. 2 . 12% SDS-PAGE of the total proteins bound after fetuinagarose affinity chromatography of H. pylori lysate. Lane 1: H. pylori lysates were incubated with fetuin-agarose, washed three times and total proteins bound to fetuin were analysed by boiling the beads in the presence of SDS-loading buffer. Lane 2: Boiled fetuin-agarose beads with no lysate present. mutation appeared to increase overall yield of uncleaved protein and also appeared to generate some cleaved product (Fig. 4) , this product runs at a similar molecular weight to the H. pylori protein.
Glycolipid-binding specificity of His-tagged recombinant HP0721 protein
The ability of His-tagged recombinant HP0721 to bind to purified gangliosides on TLC plates was assessed (Table 1) . Recombinant His-tagged HP0721 bound strongly to GD1a, and GM 3 and showed moderate binding to GM 1 . There was only weak binding to asialo-GM 1 (Fig. 5) . These results indicate that carbohydrate sequences linked to GM 1 , GM 3 and GD1a carry the epitope required as a receptor for HP0721 and that HP0721 may have preference for terminal sialic acid residues as opposed to branched sialic acid residues. These data along with the fact that recombinant HP0721 both untagged and His-tagged proteins bound to fetuin-agarose may imply that HP0721 is a sialic acid-specific adhesin.
Inhibition of H. pylori binding to epithelial cells
Inhibition of wild-type H. pylori strain 26695 and a DHP0721 mutant binding to AGS epithelial cells was measured by pre-incubating the bacteria with test compounds including a(2,3)-sialyllactose and fetuin (Sigma-Aldrich, Poole, Dorset, UK). The wild-type 26695 strain bound to AGS cells and this binding was shown to be inhibited by both fetuin and to a greater degree to a(2,3)-sialyllactose (Fig. 6) . The HP0721 mutant also bound to AGS cells and was inhibited by fetuin and a(2,3)-sialyllactose in the same manner as wild-type 26695.
Discussion
In this study, we have identified a potential sialic acid-binding protein using fetuin-agarose affinity chromatography followed by cleavage of the a(2,3) and 
NeuAca2-3Galb1-4Glcb1-1Cer ++++ a Binding to glycolipids separated on HPTLC is graded as follows: ++++, strong binding; +++, good binding; ++, moderate binding and +, weak binding. a(2,6) linkages of sialic acids using neuraminidase. This protein was identified by MALDI-TOF as a protein with unknown function with gene number HP0721. The protein has a typical signal sequence but has no obvious transmembrane b-sheet domains although it has previously been shown to be cell surfaced localised using selective biotinylation [12] . The protein does possess an amphipathic a-helix, which it could use to anchor itself on the outer membrane, or to form stable interactions with other surface localised proteins. In the primary amino acid sequence of the protein, a hexapeptide motif can be found that is shared by other wellcharacterised bacterial sialic acid-binding protein, including K99, CT-B and CFA-I. This motif consists of a region of at least three basic residues within a seven amino acid stretch (KKxxxK), which previous reports have shown that if these residues were mutated in K99 to neutral residues, binding to sialic acid was abolished [22] [23] [24] . This region could potentially form part of the receptor-binding domain in the HP0721 protein. However, analysis of outer-membrane proteins of H. pylori shows that there is a high propensity for this sequence (Bennett and Roberts, unpublished results) and this probably reflects the basic nature of many H. pylori proteins. As such, one must be cautious in interpreting this observation.
The recombinant HP0721 protein has been expressed in E. coli, to produce untagged and Histagged forms. The proteins migrated aberrantly on SDS-PAGE when compared to native HP0721 from H. pylori. N-terminal sequencing has revealed that the signal sequence of recombinant HP0721 is not being processed and this contributes to its aberrant mobility on SDS-PAGE. Site-directed mutagenesis of the leucine residue in position À3 to the predicted cleavage site to an alanine has been successful and expression of this mutated gene resulted in greater production of unprocessed HP0721 protein and a band at a molecular weight of processed product was visualised. This may suggest that in order for H. pylori proteins that possess a leucine in the À3 position to be successfully expressed, correctly processed and be directed to the outer membrane in E. coli, the leucine should be mutated to an alanine residue.
Both His-tagged and untagged recombinant HP0721 bind to fetuin-agarose, and His-tagged HP0721 appeared to bind preferentially to sialylated structures on TLC overlay experiments. This suggests that HP0721 is able to bind to sialic acid residues, and based on the increased binding to GD1a ganglioside, preferentially to terminal sialic acid residues. The binding of strain 26695 was inhibited by the addition of fetuin and a(2,3)-sialyllactose (Fig. 6) indicating that interactions involving sialic residues on the surface of AGS cells and receptors on the surface of H. pylori are important in mediating this interaction. The lack of a functional SabA adhesin in strain 26695 [11] would indicate that there must be other sialic acid-binding proteins on the surface of strain 26695. The observation that the DHP0721 mutant showed a slight reduction in binding to AGS cells as compared to the wild-type strain 26695 in keeping with HP0721 functioning as an adhesin. However, the binding of the DHP0721 mutant was still inhibited by fetuin and a(2,3)-sialyllactose to the same extent as wild-type 26695 indicating that other sialic acid-binding proteins are likely to exist on the surface of strain 26695 in addition to HP0721. As such, it is likely that interactions between H. pylori and host cells are likely to be multifactorial with a number of cell surface proteins capable of mediating microbe/host interactions. The fact that sialic acid residues are scant in healthy stomach tissue but increase during inflammation [11] , would suggest that interactions with sialic acid may be important in the longer term survival and the maintenance of a chronic state. Indeed, it is possible that sialic acid-binding proteins such as HP0721 may have less to do with mediating high affinity adhesion, but more to do with sequestering free sialic acid residues that will build up at sites of inflammation. The binding of sialic acid may be the first step in the use of sialic acid as a source of nutrients or as it may be to moderate the local inflammatory response. Experiments are in progress to further establish the role of HP0721 in the pathology of H. pylori infections.
